BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 17503131)

  • 1. Qualitative and quantitative assessment of fatigue in multiple sclerosis (MS).
    Greim B; Benecke R; Zettl UK
    J Neurol; 2007 May; 254 Suppl 2():II58-64. PubMed ID: 17503131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of quality of life in relapsing-remitting and progressive multiple sclerosis.
    Yalachkov Y; Soydaş D; Bergmann J; Frisch S; Behrens M; Foerch C; Gehrig J
    Mult Scler Relat Disord; 2019 May; 30():33-37. PubMed ID: 30735970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis.
    Ghajarzadeh M; Jalilian R; Eskandari G; Ali Sahraian M; Reza Azimi A
    Disabil Rehabil; 2013 Aug; 35(18):1509-12. PubMed ID: 23237227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
    Pavsic K; Pelicon K; Ledinek AH; Sega S
    Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective cognitive complaints relate to mild impairment of cognition in multiple sclerosis.
    Marrie RA; Chelune GJ; Miller DM; Cohen JA
    Mult Scler; 2005 Feb; 11(1):69-75. PubMed ID: 15732269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment differs between primary progressive and relapsing-remitting MS.
    Ruet A; Deloire M; Charré-Morin J; Hamel D; Brochet B
    Neurology; 2013 Apr; 80(16):1501-8. PubMed ID: 23516324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of health anxiety in patients with relapsing remitting multiple sclerosis: Misperception, misattribution and quality of life.
    Hayter AL; Salkovskis PM; Silber E; Morris RG
    Br J Clin Psychol; 2016 Nov; 55(4):371-386. PubMed ID: 26806805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatigue and its relationships with cognitive functioning and depression in paediatric multiple sclerosis.
    Goretti B; Portaccio E; Ghezzi A; Lori S; Moiola L; Falautano M; Viterbo R; Patti F; Vecchio R; Pozzilli C; Bianchi V; Cappiello S; Comi G; Trojano M; Amato MP;
    Mult Scler; 2012 Mar; 18(3):329-34. PubMed ID: 21844064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Muscle Fatigability During a Sustained Index Finger Abduction and Depression Scores Are Associated With Perceived Fatigue in Patients With Relapsing-Remitting Multiple Sclerosis.
    Wolkorte R; Heersema DJ; Zijdewind I
    Neurorehabil Neural Repair; 2015 Sep; 29(8):796-802. PubMed ID: 25605633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does fatigue occur in MS patients without disability?
    Alvarenga-Filho H; Papais-Alvarenga RM; Carvalho SR; Clemente HN; Vasconcelos CC; Dias RM
    Int J Neurosci; 2015 Feb; 125(2):107-15. PubMed ID: 24697509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fatigue scores correlate with other self-assessment data, but not with clinical and biomarker parameters, in CIS and RRMS.
    Håkansson I; Johansson L; Dahle C; Vrethem M; Ernerudh J
    Mult Scler Relat Disord; 2019 Nov; 36():101424. PubMed ID: 31586802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational validity of PASAT and the effect of fatigue and mood in patients with relapsing remitting MS: A functional MRI study.
    Iancheva D; Trenova AG; Terziyski K; Kandilarova S; Mantarova S
    J Eval Clin Pract; 2018 Aug; 24(4):832-838. PubMed ID: 29611255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial.
    Coghe G; Corona F; Marongiu E; Fenu G; Frau J; Lorefice L; Crisafulli A; Galli M; Concu A; Marrosu MG; Pau M; Cocco E
    J Neurol; 2018 Jun; 265(6):1328-1333. PubMed ID: 29574556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The psychosocial and cognitive impact of longstanding 'benign' multiple sclerosis.
    Sayao AL; Bueno AM; Devonshire V; Tremlett H;
    Mult Scler; 2011 Nov; 17(11):1375-83. PubMed ID: 21677023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intensive social cognitive treatment (can do treatment) with participation of support partners in persons with relapsing remitting multiple sclerosis: observation of improved self-efficacy, quality of life, anxiety and depression 1 year later.
    Jongen PJ; Heerings M; Ruimschotel R; Hussaarts A; Duyverman L; van der Zande A; Valkenburg-Vissers J; van Droffelaar M; Lemmens W; Donders R; Visser LH
    BMC Res Notes; 2016 Jul; 9():375. PubMed ID: 27473375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerobic exercise increases irisin serum levels and improves depression and fatigue in patients with relapsing remitting multiple sclerosis: A randomized controlled trial.
    Bilek F; Cetisli-Korkmaz N; Ercan Z; Deniz G; Demir CF
    Mult Scler Relat Disord; 2022 May; 61():103742. PubMed ID: 35349884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What you get from what you see: Parametric assessment of visual processing capacity in multiple sclerosis and its relation to cognitive fatigue.
    Kluckow SW; Rehbein JG; Schwab M; Witte OW; Bublak P
    Cortex; 2016 Oct; 83():167-80. PubMed ID: 27552137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Network analysis characterizes key associations between subjective fatigue and specific depressive symptoms in early relapsing-remitting multiple sclerosis.
    Chang YT; Kearns PKA; Carson A; Gillespie DC; Meijboom R; Kampaite A; Valdés Hernández MDC; Weaver C; Stenson A; MacDougall N; O'Riordan J; Macleod MA; Carod-Artal FJ; Connick P; Waldman AD; Chandran S; Foley P
    Mult Scler Relat Disord; 2023 Jan; 69():104429. PubMed ID: 36493562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of depression and fatigue on relapsing remitting multiple sclerosis in Kingdom of Saudi Arabia.
    Alshamrani FJ; Almuaigel MF; Alkhamis FA; Alsulaiman AA; AlMohish NM; Albuhassah AF; AlZahrani AS; Mahmoud Zaher AA
    Saudi Med J; 2020 Mar; 41(3):290-295. PubMed ID: 32114602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Memory performance in multiple sclerosis patients correlates with central brain atrophy.
    Hildebrandt H; Hahn HK; Kraus JA; Schulte-Herbrüggen A; Schwarze B; Schwendemann G
    Mult Scler; 2006 Aug; 12(4):428-36. PubMed ID: 16900756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.